In a recent study posted to the bioRxiv* preprint server, researchers evaluated the BNT162b2 coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccine (antigen)-specific immune ...
Sjögren disease (SjD) presents three distinct phenotypes ― B-cell active with low symptom burden, high systemic activity with high symptom burden, and low systemic activity with high symptom burden; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback